Dyne Therapeutics Inc (DYN) Event Aug. 04, 2022, 11:36 UTC (30% Negative) Dyne Therapeutics, Inc. (DYN) Reports Q3 2022 Financial Results Full text
Register to leave comments News bot Oct. 2, 2025, 5:55 p.m. 📋 Dyne Therapeutics, Inc. (DYN) - Financial Results Filing Date: 2022-08-04 Accepted: 2022-08-04 07:36:53 Event Type: Financial Results Event Details: Dyne Therapeutics Inc (DYN) Reports Q3 2022 Financial Results Dyne Therapeutics Inc (DYN) announced its financial results for the period ending Q3 2022. Key Financial Highlights: Revenue: Not disclosed Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: 291838 Initiation of Patient Dosing in Multiple Ascending Dose Clinical Trials for DYNE101 in DM1 On Track for MidWALTHAM, Mass., August 4, 2022 – Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2022 2021 Change ($) Change (%) Operating Expenses Loss From Operations 30.16K 88.54K $-58.37K -65.93% Operating Expenses Net Loss 29.95K 87.89K $-57.93K -65.92% Operating Expenses Net Loss Per Share 0.58 1.70 $-1.12 -65.88% Assets Cash Equivalents Marketable Securities 291.84K 376.57K $-84.73K -22.50% Assets Other Assets 48.19K 49.09K $-904.00 -1.84% Loss from Operations 52.76K 30.16K $22.59K +74.89% Net Loss 52.30K 29.95K $22.35K +74.61% Cash and Marketable Securities 291.84K 376.57K $-84.73K -22.50% Other Assets 48.19K 49.09K $-904.00 -1.84% 💼 Business Developments: No business developments data available. Structured Data: Company Name: Dyne Therapeutics IncCIK: 0001818794Ticker Symbol: DYNPeriod End Date: 2022-08-04Document Type: 8-K
📋 Dyne Therapeutics, Inc. (DYN) - Financial Results
Filing Date: 2022-08-04
Accepted: 2022-08-04 07:36:53
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
No business developments data available.
Structured Data: